🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an observational, longitudinal, prospective study for sample collec...
Status
Active Not Recruiting
Location
Institute of Human Virology, University of Maryland School of Medicine
Start Date
2014-12
Trial ID
NCT02995252
This is a study to look at whether the presence of circulating tumour DNA (...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2022-03-28
Trial ID
NCT04966663
Treatments Being Tested
This is an ancillary laboratory study to collect and bank blood and tissue ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07550049
Treatments Being Tested
This phase III trial compares the effect of sentinel lymph node mapping to ...
Status
Recruiting
Location
George Washington University Medical Center
Start Date
2022-12-07
Trial ID
NCT05646316
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
Background: Breast cancer ranks first among cancer types seen in women in o...
Status
Completed
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT04729647
Treatments Being Tested
The purpose of this research is to identify biological characteristics occu...
Status
Recruiting
Location
Vanderbitl-Ingram Cancer Center
Start Date
2010-06-03
Trial ID
NCT01205815
Treatments Being Tested
Recent advances in understanding how cancer develops and spreads have led t...
Status
Recruiting
Location
The Christie
Start Date
2018-11-14
Trial ID
NCT04493723
Treatments Being Tested
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713